We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Enforcement Efforts Prove Costly to Device and Drug Industries
Enforcement Efforts Prove Costly to Device and Drug Industries
November 24, 2010
The scope of the Justice Department’s stepped-up enforcement campaign against off-label marketing and other violations of the False Claims Act is coming into focus, with the agency saying it has recovered nearly $5 billion in taxpayer funds from the healthcare industry since January 2009.